Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
4088122
Reference Type
Journal Article
Title
Nicotine, carcinogen, and toxin exposure in long-term e-cigarette and nicotine replacement therapy users: A cross-sectional study
Author(s)
Shahab, L; Goniewicz, ML; Blount, BC; Brown, J; Mcneill, A; Alwis, KU; Feng, J; Wang, L; West, R
Year
2017
Is Peer Reviewed?
Yes
Journal
Annals of Internal Medicine
ISSN:
0003-4819
EISSN:
1539-3704
Volume
166
Issue
6
Page Numbers
390-400
Language
English
PMID
28166548
DOI
10.7326/M16-1107
Web of Science Id
WOS:000397025800014
URL
http://
://WOS:000397025800014
Exit
Abstract
Background:
Given the rapid increase in the popularity of e-cigarettes and the paucity of associated longitudinal health-related data, the need to assess the potential risks of long-term use is essential.
Objective:
To compare exposure to nicotine, tobacco-related carcinogens, and toxins among smokers of combustible cigarettes only, former smokers with long-term e-cigarette use only, former smokers with long-term nicotine replacement therapy (NRT) use only, long-term dual users of both combustible cigarettes and e-cigarettes, and long-term users of both combustible cigarettes and NRT.
Design:
Cross-sectional study.
Setting:
United Kingdom.
Participants:
The following 5 groups were purposively recruited: combustible cigarette-only users, former smokers with long-term (≥6 months) e-cigarette-only or NRT-only use, and long-term dual combustible cigarette-e-cigarette or combustible cigarette-NRT users (n = 36 to 37 per group; total n = 181).
Measurements:
Sociodemographic and smoking characteristics were assessed. Participants provided urine and saliva samples and were analyzed for biomarkers of nicotine, tobacco-specific N-nitrosamines (TSNAs), and volatile organic compounds (VOCs).
Results:
After confounders were controlled for, no clear between-group differences in salivary or urinary biomarkers of nicotine intake were found. The e-cigarette-only and NRT-only users had significantly lower metabolite levels for TSNAs (including the carcinogenic metabolite 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol [NNAL]) and VOCs (including metabolites of the toxins acrolein; acrylamide; acrylonitrile; 1,3-butadiene; and ethylene oxide) than combustible cigarette-only, dual combustible cigarette-e-cigarette, or dual combustible cigarette-NRT users. The e-cigarette-only users had significantly lower NNAL levels than all other groups. Combustible cigarette-only, dual combustible cigarette-NRT, and dual combustible cigarette-e-cigarette users had largely similar levels of TSNA and VOC metabolites.
Limitation:
Cross-sectional design with self-selected sample.
Conclusion:
Former smokers with long-term e-cigarette-only or NRT-only use may obtain roughly similar levels of nicotine compared with smokers of combustible cigarettes only, but results varied. Long-term NRT-only and e-cigarette-only use, but not dual use of NRTs or e-cigarettes with combustible cigarettes, is associated with substantially reduced levels of measured carcinogens and toxins relative to smoking only combustible cigarettes.
Primary Funding Source:
Cancer Research UK.
Keywords
Adult; Biomarkers/analysis/urine; Carcinogens/analysis; Cross-Sectional Studies; Electronic Nicotine Delivery Systems/adverse effects; Nicotine/analysis/urine; Nitrosamines/analysis/urine; Salvia/chemistry; Smoking Cessation/methods; Time Factors; Tobacco Use Cessation Devices/adverse effects; Volatile Organic Compounds/analysis/urine; 6M3C89ZY6R
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity